| Financial Year |
March 31 2021 |
| Monetary Funds |
411,766,606.08 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
3,974,043.11 |
| Advances to Suppliers |
1,487,403.05 |
| Other Receivables |
26,838,266.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
332,344,850.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,701,066.99 |
| Total Current Assets |
781,112,236.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
14,350,727.50 |
| Fixed Assetes |
168,497,264.60 |
| Under-construction Projects |
283,185.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
452,247.89 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
66,824,166.54 |
| R&D expenses |
-- |
| Goodwill |
10,890,883.28 |
| Long-Term Deferred and Prepaid Expenses |
13,781,121.48 |
| Deferred Income Tax Assets |
99,276.98 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
285,850,010.93 |
| Total Assets |
1,066,962,247.40 |
| Short-Term Loans |
556,841,459.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
60,000,000.00 |
| Accounts Payable |
125,450,927.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,632,614.60 |
| Taxes Payable |
167,242,799.27 |
| Interest Payable |
450,730,842.60 |
| Dividend Payable |
561,753.59 |
| Other payables |
667,113,974.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
870,800,000.00 |
| Other Current Liabilities |
2,209,933.99 |
| Sub-Total of Current Liabilities |
2,488,295,476.92 |
| Long-term Loans |
-- |
| Bonds Payable |
497,697,613.47 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
310,281,900.00 |
| Deferred Income Tax Liabilities |
9,203,227.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
825,257,307.76 |
| Total Liabilities |
3,313,552,784.68 |
| Paid-In Capital(Or Share Stock) |
617,585,803.00 |
| Capital Surplus |
1,500,932,518.93 |
| Surplus Reserve |
89,289,828.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-4,461,576,362.69 |
| Minority Stockholder's Interest |
6,997,768.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-2,253,588,305.29 |
| Owner's Equity（Stockholder's Equity） |
-2,246,590,537.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,066,962,247.40 |
